Elite Life Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Elite Life Management's LLY Position: Q2 2026 in Review
Elite Life Management increased its Eli Lilly (LLY) stake by 3.5% in Q2 2026, buying an estimated $21.5K and bringing the position to 617 shares worth $721K. The position accounts for 0.84% of the portfolio, ranked #18.
Elite Life Management first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Elite Life Management held 617 shares of Eli Lilly worth $721K as of Q2 2026.
- Elite Life Management bought 21 Eli Lilly shares in Q2 2026, an estimated $21.5K.
- Eli Lilly made up 0.84% of Elite Life Management's portfolio in Q2 2026, its #18 holding.
- Elite Life Management first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
- 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Elite Life Management's 13F filing for Q2 2026, filed 6 Aug 2026.